Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$799,841
-$121,941 QoQ
Shares Held
33,216
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,457
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $25,620,221 across 16 Drug Manufacturers - General names. PFE ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,837 | $5,545,942 | |
| 2 | ABBV |
AbbVie Inc.
|
19,010 | $4,783,676 | |
| 3 | LLY |
ELI LILLY & Co
|
3,909 | $4,688,572 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,199 | $4,651,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,282 | $1,678,047 | |
| 6 | AMGN |
Amgen Inc
|
4,076 | $1,476,001 | |
| 7 | PFE |
Pfizer Inc
This page
|
33,216 | $799,841 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,165 | $758,567 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $799,841 | 33,216 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $921,782 | 32,827 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $753,050 | 30,243 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,215,115 | 47,689 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,212,121 | 50,005 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,207,298 | 47,644 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,250,544 | 47,137 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,267,890 | 43,811 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,217,409 | 43,510 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,196,940 | 43,133 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,234,687 | 42,886 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,541,078 | 46,460 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,711,598 | 46,663 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,664,844 | 40,805 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,086,800 | 40,726 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,919,838 | 43,872 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,234,566 | 42,620 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,102,431 | 40,611 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,565,191 | 43,441 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,954,632 | 45,446 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,672,249 | 42,703 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,475,901 | 40,737 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,450,203 | 39,397 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,397,314 | 38,074 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,540,662 | 47,115 | Shares | Sole | 2020-09-28 | |
| 2020-03-31 | $1,537,831 | 47,115 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||